Stay updated on First-in-Human Study of EYP-1901 in wAMD Clinical Trial
Sign up to get notified when there's something new on the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page.

Latest updates to the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedDeleted a government funding/operating status notice and added Revision: v3.4.2.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the version to v3.4.1. Removed the previous version v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedNew 'Show glossary' option added. Minor copy changes update capitalization for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and introduce a 'Revision: v3.4.0' note.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter shows Revision: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section has been added, listing participating sites by state (Arizona, California, Florida, Massachusetts, North Carolina, Pennsylvania, Texas). The page version has been updated to v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.9%

- Check85 days agoChange DetectedThe page shows an updated revision line: Revision: v3.3.2, replacing the previous v3.3.1. This appears to be a technical revision with no changes to study data or page content.SummaryDifference0.1%

Stay in the know with updates to First-in-Human Study of EYP-1901 in wAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page.